Focal S100A4 Protein Expression Is an Independent Predictor of Development of Metastatic Disease in Cystectomized Bladder Cancer Patients
- 31 October 2006
- journal article
- Published by Elsevier BV in European Urology
- Vol. 50 (4), 777-785
- https://doi.org/10.1016/j.eururo.2006.02.027
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinomaBritish Journal of Cancer, 2005
- The metastasis associated protein S100A4: role in tumour progression and metastasisBritish Journal of Cancer, 2005
- Transfection of S100A4 Produces Metastatic Variants of an Orthotopic Model of Bladder CancerThe American Journal of Pathology, 2002
- The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factorOncogene, 2001
- Tumor Suppressor p53 Protein Is a New Target for the Metastasis-associated Mts1/S100A4 ProteinJournal of Biological Chemistry, 2001
- S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional rolesThe International Journal of Biochemistry & Cell Biology, 2001
- Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancerInternational Journal of Cancer, 2000
- Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cellsOncogene, 1998
- Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cellsOncogene, 1997
- The S100 family of EF-hand calcium-binding proteins: functions and pathologyTrends in Biochemical Sciences, 1996